Bioactivity:

Myriceric acid B is a potent HIV-1 entry inhibitor targeting gp41 and can serve as a lead compound for developing novel anti-HIV-1 drug. Myriceric acid B scavenges DPPH free radicals with IC50 value of 21.8 uM, it inhibits aromatase activity with IC50 val

CAS nr:

55497-79-5

Purity:

98%

Molecular Weight:

634,9

SMILES:

CC1(C)CC[C@@]2(CC[C@]3(COC(=O)\C=C\c4ccc(O)c(O)c4)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O

Formula:

C39H54O7

Pathway:

Proteases/Proteasome,Microbiology/Virology

Target:

HIV Protease,HIV Protease